377 related articles for article (PubMed ID: 26385727)
1. Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada.
Blanc-Lapierre A; Spence A; Karakiewicz PI; Aprikian A; Saad F; Parent MÉ
BMC Public Health; 2015 Sep; 15():913. PubMed ID: 26385727
[TBL] [Abstract][Full Text] [Related]
2. Use of oral anticoagulants and risk of prostate cancer: a population-based case-control study in Montreal, Canada.
Blanc-Lapierre A; Weiss D; Parent MÉ
Cancer Causes Control; 2014 Sep; 25(9):1159-66. PubMed ID: 24946744
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
[TBL] [Abstract][Full Text] [Related]
4. General and abdominal obesity trajectories across adulthood, and risk of prostate cancer: results from the PROtEuS study, Montreal, Canada.
Vallières E; Mésidor M; Roy-Gagnon MH; Richard H; Parent MÉ
Cancer Causes Control; 2021 Jun; 32(6):653-665. PubMed ID: 33818663
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study.
Sourbeer KN; Howard LE; Andriole GL; Moreira DM; Castro-Santamaria R; Freedland SJ; Vidal AC
BJU Int; 2015 May; 115(5):736-43. PubMed ID: 24931061
[TBL] [Abstract][Full Text] [Related]
6. Occupation, industry, and the risk of prostate cancer: a case-control study in Montréal, Canada.
Sauvé JF; Lavoué J; Parent MÉ
Environ Health; 2016 Oct; 15(1):100. PubMed ID: 27769264
[TBL] [Abstract][Full Text] [Related]
7. Actual lowering effect of metabolic syndrome on serum prostate-specific antigen levels is partly concealed by enlarged prostate: results from a large-scale population-based study.
Zhao S; Xia M; Tang J; Yan Y
BJU Int; 2017 Oct; 120(4):482-489. PubMed ID: 27489082
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Health Status and Metabolic Syndrome in Adults Living in a Transition European Country: Findings from a Population-Based Study.
Stojisavljević D; Janković J; Erić M; Marinković J; Janković S
J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):568-574. PubMed ID: 29097061
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
Nam GE; Kim SM; Han K; Kim NH; Chung HS; Kim JW; Han B; Cho SJ; Yu JH; Park YG; Choi KM
PLoS Med; 2018 Aug; 15(8):e1002640. PubMed ID: 30130376
[TBL] [Abstract][Full Text] [Related]
10. Residential greenness and risk of prostate cancer: A case-control study in Montreal, Canada.
Demoury C; Thierry B; Richard H; Sigler B; Kestens Y; Parent ME
Environ Int; 2017 Jan; 98():129-136. PubMed ID: 27823799
[TBL] [Abstract][Full Text] [Related]
11. Traffic-related air pollution and prostate cancer risk: a case-control study in Montreal, Canada.
Parent MÉ; Goldberg MS; Crouse DL; Ross NA; Chen H; Valois MF; Liautaud A
Occup Environ Med; 2013 Jul; 70(7):511-8. PubMed ID: 23531743
[TBL] [Abstract][Full Text] [Related]
12. Circumcision and prostate cancer: a population-based case-control study in Montréal, Canada.
Spence AR; Rousseau MC; Karakiewicz PI; Parent MÉ
BJU Int; 2014 Dec; 114(6b):E90-E98. PubMed ID: 24655933
[TBL] [Abstract][Full Text] [Related]
13. BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS).
Boehm K; Valdivieso R; Meskawi M; Larcher A; Sun M; Sosa J; Blanc-Lapierre A; Weiss D; Graefen M; Saad F; Parent MÉ; Karakiewicz PI
World J Urol; 2015 Dec; 33(12):2063-9. PubMed ID: 25824539
[TBL] [Abstract][Full Text] [Related]
14. Trace proteinuria by dipstick screening is associated with metabolic syndrome, hypertension, and diabetes.
Okada R; Yasuda Y; Tsushita K; Wakai K; Hamajima N; Matsuo S
Clin Exp Nephrol; 2018 Dec; 22(6):1387-1394. PubMed ID: 29934666
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy.
Lebdai S; Mathieu R; Leger J; Haillot O; Vincendeau S; Rioux-Leclercq N; Fournier G; Perrouin-Verbe MA; Doucet L; Azzouzi AR; Rigaud J; Renaudin K; Charles T; Bruyere F; Fromont G
Urol Oncol; 2018 Feb; 36(2):80.e17-80.e24. PubMed ID: 29153942
[TBL] [Abstract][Full Text] [Related]
16. Components of metabolic syndrome and prognosis of renal cell cancer.
Eskelinen TJ; Kotsar A; Tammela TLJ; Murtola TJ
Scand J Urol; 2017 Dec; 51(6):435-441. PubMed ID: 28743221
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study.
Montella M; Di Maso M; Crispo A; Grimaldi M; Bosetti C; Turati F; Giudice A; Libra M; Serraino D; La Vecchia C; Tambaro R; Cavalcanti E; Ciliberto G; Polesel J
BMC Cancer; 2015 Oct; 15():720. PubMed ID: 26475132
[TBL] [Abstract][Full Text] [Related]
18. The metabolic syndrome and risk of prostate cancer in Italy.
Pelucchi C; Serraino D; Negri E; Montella M; Dellanoce C; Talamini R; La Vecchia C
Ann Epidemiol; 2011 Nov; 21(11):835-41. PubMed ID: 21982487
[TBL] [Abstract][Full Text] [Related]
19. Waist circumference, waist-hip ratio, body mass index, and prostate cancer risk: results from the North-American case-control study Prostate Cancer & Environment Study.
Boehm K; Sun M; Larcher A; Blanc-Lapierre A; Schiffmann J; Graefen M; Sosa J; Saad F; Parent MÉ; Karakiewicz PI
Urol Oncol; 2015 Nov; 33(11):494.e1-7. PubMed ID: 26278366
[TBL] [Abstract][Full Text] [Related]
20. Spatial variations in ambient ultrafine particle concentrations and the risk of incident prostate cancer: A case-control study.
Weichenthal S; Lavigne E; Valois MF; Hatzopoulou M; Van Ryswyk K; Shekarrizfard M; Villeneuve PJ; Goldberg MS; Parent ME
Environ Res; 2017 Jul; 156():374-380. PubMed ID: 28395241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
